唾液MMP-9与S100A8对牙周炎的诊断和预后价值
本研究纳入149名参与者(99例牙周炎、50例健康),其中74例牙周炎患者接受非手术治疗后3个月复诊。唾液MMP-9和S100A8与牙周炎相关(p<.05),联合算法的筛查能力为0.86(p<.05);治疗后唾液S100A8和MMP-9的降低率分别为83.7%和23.5%(p<.05),仅S100A8优于临床参数。结论:联合算法诊断效能高,两者均有预后能力但S100A8更优。
要点
- 唾液MMP-9和S100A8联合算法对牙周炎筛查能力达0.86。
- 非手术治疗后唾液S100A8降低率83.7%,MMP-9降低率23.5%。
- S100A8的预后能力优于临床参数,MMP-9次之。
核心结论
- 唾液MMP-9和S100A8联合算法对牙周炎具有高诊断效能。
- 唾液S100A8和MMP-9均具有预后能力,但S100A8更优。
研究设计与样本
- 共纳入149名参与者,其中牙周炎99例、健康50例。
- 99例非手术牙周炎治疗参与者中74例在3个月后复诊。
- 牙周炎按2018年新分类分为II-IV期。
- 采用酶联免疫吸附试验定量唾液MMP-9和S100A8。
- 诊断能力用受试者工作特征曲线评估,预后能力用配对t检验评估治疗前后标志物变化。
主要发现
- 唾液MMP-9和S100A8与牙周炎相关(p<.05)。
- 唾液MMP-9和S100A8联合算法对牙周炎的筛查能力为0.86(p<.05)。
- 治疗后唾液S100A8降低率为83.7%(p<.05)。
- 治疗后唾液MMP-9降低率为23.5%(p<.05)。
- 仅唾液S100A8在预后评估上优于临床参数。
关键数值与推荐
- 牙周炎诊断分类采用2018年新分类的II-IV期标准。
- 唾液MMP-9和S100A8联合算法筛查牙周炎的曲线下面积为0.86(p<.05)。
- 治疗后唾液S100A8降低率83.7%、MMP-9降低率23.5%(p<.05)。
临床怎么用
- 唾液MMP-9和S100A8联合算法可作为牙周炎筛查的辅助工具。
- 唾液S100A8可用于监测非手术治疗后的预后反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Salivary diagnostic using matrix metalloproteinase (MMP) and S100 for periodontitis is a promising issue. However, its prognostic effect is still unclear. This study aimed to evaluate the prognostic ability of salivary MMP-9 and S100A8 for periodontitis through non-surgical periodontitis treatment clinical trial. MATERIALS AND METHODS: Total 149 participants, 99 periodontitis and 50 healthy, were recruited. Among 99 non-surgical periodontitis treatment participants, 74 participants were revisited after three months. Periodontitis was classified as stage II-IV of new classification of periodontitis proposed at 2018. Enzyme-linked immunosorbent assay kit was used to quantify salivary MMP-9 and S100A8. Receiver operating characteristic curve was applied for diagnostic ability. Paired t test was applied for prognostic ability evaluating changes in salivary markers between pre- and post-treatment. RESULTS: Salivary MMP-9 and S100A8 were associated with periodontitis (p < .05). The screening ability of algorithm using salivary MMP-9 and S100A8 for periodontitis was 0.86 (p < .05). After treatment, reduction rate of salivary S100A8 and MMP-9 was 83.7% and 23.5%, respectively, (p < .05): only salivary S100A8 was superior compared to clinical parameters. CONCLUSION: Algorithm using salivary MMP-9 and S100A8 showed high diagnostic power for periodontitis. Both salivary S100A8 and MMP-9 showed prognostic ability for periodontitis, but S100A8 was better.
引用
- Kim HD, Kim S, Jeon S, et al. Diagnostic and Prognostic ability of salivary MMP-9 and S100A8 for periodontitis. J Clin Periodontol. 2020. PMID: 32744384. doi:10.1111/jcpe.13349
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。